• DOI:10.1097/YCO.0b013e3282f52851
Corpus ID: 34935

New generation antipsychotic drugs and compliance behaviour

@article{Voruganti2008NewGA,
  title={New generation antipsychotic drugs and compliance behaviour},
  author={L. Voruganti and Laura K Baker and A. Awad},
  journal={Current Opinion in Psychiatry},
  year={2008},
  volume={21},
  pages={133–139}
}

• L. Voruganti, Laura K Baker, A. Awad
• Published 2008
• Medicine
• Current Opinion in Psychiatry

Purpose of review Antipsychotic therapy has been eclipsed by high rates of noncompliance; the problem was attributed to a lack of efficacy and the burden of side effects of neuroleptics. This review sought to examine whether the arrival of second generation (atypical) antipsychotic drugs with low side-effect liability and improved efficacy has helped to positively reinforce compliance behaviour among people treated for schizophrenia. Recent findings The number of studies that systematically… Expand